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Abstract
Mendelian randomization (MR) is a popular method in genetic epidemiology to estimate the
effect of an exposure on an outcome using genetic variants as instrumental variables (IV), with
two-sample summary-data MR being the most popular due to privacy. Unfortunately, many
MR methods for two-sample summary data are not robust to weak instruments, a common
phenomena with genetic instruments; many of these methods are biased and no existing MR
method has Type I error control under weak instruments. In this work, we propose test statistics
that are robust to weak instruments by extending Anderson-Rubin, Kleibergen, and conditional
likelihood ratio tests in econometrics to the two-sample summary data setting. We conclude
with a simulation and an empirical study and show that the proposed tests control size and
have better power than current methods.
Key words: Instrumental variables; Mendelian randomization; two-sample summary-data
Mendelian randomization; weak instrument asymptotics.
1 Introduction
Recently, Mendelian randomization (MR) is a popular method in genetic epidemiology to study the
effect of modifiable exposures on health outcomes by using genetic variants as instrumental vari-
ables (IV). In a nutshell, MR finds instruments, typically single nucleotide polymorphisms (SNPs),
from publicly available genome-wide association studies (GWAS) and the instruments must be (A1)
associated with the exposure; (A2) independent of the unmeasured confounder; and (A3) indepen-
dent of the outcome variable after conditioning on the exposure (Davey Smith and Ebrahim, 2003;
∗shengw@stat.wisc.edu
†hyunseung@stat.wisc.edu
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Lawlor et al., 2008) Typically, two non-overlapping GWAS are used to find instruments, one GWAS
studying the exposure and another GWAS studying the outcome. Also, due to privacy, when esti-
mating the exposure effect, only summary statistics instead of individual-level data are extracted
for analysis. This setup is commonly known as two-sample summary-data MR (Pierce and Burgess,
2013; Burgess et al., 2013, 2015).
The focus of this paper is on testing the exposure effect in two-sample summary-data MR when
(A1) is violated, or more precisely when the instruments are weakly associated with the exposure.
Many genetic instruments in MR studies only explain a fraction of the variation in the exposure.
Using these weak instruments can introduce bias and inflate Type I errors (Burgess and Thompson,
2011). Weak IVs can also amplify bias fromminor violations of (A2) and (A3) (Small and Rosenbaum,
2008). Unfortunately, many popular MR methods and software assume instruments are strongly
associated with the exposure; many go one step further and assume that the correlation between
each instrument and exposure has no sampling error (Bowden et al., 2016b). For example, methods
such as the inverse-variance weighted estimator (IVW) (Burgess et al., 2013), MR-Egger regression
(Bowden et al., 2015), weighted median estimator (W.Median) (Bowden et al., 2016a) and the
modal estimator (Hartwig et al., 2017) typically assume that each instrument’s correlation to the
exposure of interest is measured without error. In Section 4, we numerically demonstrate the se-
riousness of making such assumptions in MR by “stress-testing” these methods’ performance on a
real MR data set, akin to an exercise done by Bound et al. (1995) in econometrics for single-sample,
individual-level data.
Many works in econometrics have dealt with weak instruments; see Stock et al. (2002) for an
overview. In particular, the Anderson-Rubin (AR) test (Anderson et al., 1949), the Kleibergen (K)
test (Kleibergen, 2002), and the conditional likelihood ratio (CLR) test (Moreira, 2003) provide
Type I error control regardless of instruments’ magnitude of association to the exposure, also called
instruments’ strength. More formally, the three methods satisfy the necessary requirement for valid
1−α confidence intervals with weak instruments, where the confidence interval adapts and becomes
infinite in the presence of weak IVs to maintain 1− α coverage (Dufour, 1997). However, all these
methods assume that individual-level data is available to compute the test statistics and the data
comes from the same sample. In GWAS and MR, one rarely has access to individual-level data
due to privacy concerns and is forced to work with anonymized summary statistics from multiple
GWAS. To the best of our knowledge, no methods in two-sample summary-data MR provide Type
I error control when the relationship between the exposure and the instruments is weak, even
irrelevant.
Our contribution is to propose weak instrument robust tests for two-sample summary-data MR.
We extend the three aforementioned weak-instrument robust tests in econometrics, AR test, the
K test , and the CLR test, to work with two-sample summary data by leveraging recent work
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by Choi et al. (2018) who worked with two-sample, but individual data. We show that under
the two-sample summary-data model and weak-IV asymptotics of Staiger and Stock (1997), these
modified tests, which we call mrAR, mrK, and mrCLR, asymptotically control Type I error for
testing the exposure effect. In the supplementary materials, we also introduce point estimators
based on these tests, most notably the MR limited information maximum likelihood estimator
(mrLIML) based on taking the minimum of the mrAR test. mrLIML is similar to the original
limited information maximum likelihood (LIML) estimator (Anderson et al., 1949) and we show an
equivalence relationship between mrLIML and the recent profile-likelihood estimator proposed by
Zhao et al. (2018). We conclude with a simulation and a prototypical MR data example concerning
the effect of body mass index (BMI) on systolic blood pressure (SBP).
2 Setup and Method
2.1 Review: Two-Sample Summary Data in MR
We review the data generating model underlying MR. Suppose we have two independent groups of
people, with n1 and n2 participants each of the two groups. For each individual i in sample l = 1, 2,
let Yli ∈ R denote his/her outcome, Dli ∈ R denote his/her exposure, and Zli ∈ RL denote his/her
L instruments. Single-sample individual data MR assumes that for one sample l, Yli,Dli, Zli follows
a linear structural model common in classical econometrics (Lawlor et al., 2008).
Yli = βint +Dliβ + ǫli, Dli = γint + Z
⊺
liγ + δli, E[ǫli, δli | Zli] = 0 (1)
The parameter of interest is β and has a causal interpretation under some assumptions (Holland,
1988; Kang et al., 2016; Zhao et al., 2019). Two-sample individual-data MR assumes the same
underlying structural model (1) for both samples. But, for sample l = 1, the investigator only
sees (Y1i, Z1i) and for sample l = 2, the investigator only sees (D2i, Z2i) (Pierce and Burgess,
2013; Burgess et al., 2013); this is identical to the setup in Angrist and Krueger (1992). Finally, in
two-sample summary-data MR, only summarized statistics of (Y1i, Z1i) and (D2i, Z2i) are available.
Specifically, from n1 samples of (Y1i, Z1i), we obtain (i) Γ̂ ∈ RL where Γ̂j is the estimated association
between IV Z1ij and Y1i and (ii) Σ̂Γ ∈ RL×L, the estimated covariance of Γ̂. Similarly, from n2
samples of (D2i, Z2i), we obtain (i) γ̂ ∈ RL where γ̂j is the estimated association between IV Z2ij
and D2i and (ii) Σ̂γ ∈ RL×L, the estimated covariance of γ̂. We assume that the summary statistics
(Γ̂, Σ̂Γ, γ̂, Σ̂γ) used in the analysis satisfy the following assumptions:
Assumption 1. The IV-exposure effect γ̂ and the IV-outcome effect Γ̂ are independent, γ̂ ⊥ Γ̂.
Assumption 2. The two effect estimates are distributed as γ̂ ∼ N(γ,Σγ) and Γ̂ ∼ N(γβ,ΣΓ)
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Assumption 3. We have n1(Σ̂Γ−ΣΓ) p→ 0, n2(Σ̂γ −Σγ) p→ 0 and n1ΣΓ p→ Σ1, n2Σγ p→ Σ2, where
Σ1,Σ2 are deterministic positive-definite matrices.
Assumption 4. For some constant C ∈ RL, we have γ = C/√n1
Assumption 1 is typically satisfied in MR by having two GWAS that independently measure
SNPs’ associations to the exposure and outcome (Pierce and Burgess, 2013). Assumption 2 is
reasonable in publicly-available GWAS where the effect estimates are based on running ordinary
least square (OLS) between each instrument and exposure/outcome and since the sample size for
each GWAS is on the order of hundreds or thousands, the normality of OLS estimates is plausible.
Assumption 3 states that the estimated standard errors converge to their asymptotic variances.
Assumption 3 is plausible since the covariance matrices are estimated from OLS residual errors
and most of MR assumes that the SNPs are independent of each other. Overall, Assumptions 1-3
are common in two-sample summary-data MR (Zhao et al., 2018). Finally, Assumption 4 is also
known as weak-IV asymptotics (Staiger and Stock, 1997) and it provides an asymptotic framework
to study the behavior of IV estimators when instruments are weak.
We remark that the literature also assume the instruments are independent to each other, which
we do not explicitly impose here. Also, to focus on our contributions to weak IVs in two-sample
summary-data MR, we assume that the instruments are valid (e.g. the exclusion restriction holds).
2.2 Weak-IV Robust Tests for the Exposure Effect β
Consider the null hypothesis H0 : β = β0 and the alternative Ha : β 6= β0. We define two statistics
S(β0) ∈ RL and R(β0) ∈ RL from the summary statistics (Γ̂, Σ̂Γ, γ̂, Σ̂γ).
S(β0) =
(
Σ̂Γ + β
2
0Σ̂γ
)−1/2 (
Γ̂− β0γ̂
)
, R(β0) = (β
2
0Σ̂
−1
Γ
+ Σ̂−1γ )
−1/2
(
Σ̂−1
Γ
Γ̂β0 + Σ̂
−1
γ γˆ
)
(2)
The statistics S(β0) and R(β0) are similar to the independent sufficient statistics of β and π in the
traditional econometric setting (i.e. one-sample individual-data setting) (Moreira, 2003) or in the
two-sample individual data setting (Choi et al., 2018). A key difference is that (2) are computed
with two-sample summary data. While not exactly sufficient for β and π in our setting, S(β0) and
R(β0) is asymptotically independent as the following Lemma shows.
Lemma 1. If Assumptions 1-4 hold and n1/n2 → c ∈ (0,∞), (S(β0), R(β0)) p→ (S∞(β0), R∞(β0))
where
S∞ ∼ N [(Σ1 + cβ20Σ2)−1/2(β − β0)C, IL]
R∞ ∼ N [(β20Σ−11 + c−1Σ−12 )−1/2(β0βΣ−11 C + c−1Σ−12 C), IL]
4
and S∞ and R∞ are independent.
The asymptotic independence is crucial as it allows us to follow Moreira (2003) and Andrews et al.
(2006) and use S(β0) and R(β0) to construct AR, K, and CLR tests for two-sample summary-data
MR.
TmrAR(β0) = QS(β0) (3)
TmrK(β0) = Q
2
SR(β0)/QR(β0) (4)
TmrCLR(β0) =
1
2
(
QS(β0)−QR(β0) +
[
{QS(β0) +QR(β0)}2 − 4
{
QS(β0)QR(β0)−Q2SR(β0)
}] 1
2
)
(5)
Here, QS(β0) = S
T(β0)S(β0), QSR = S
T(β0)R(β0), and QR = R
T(β0)R(β0). Suppose χ
2
k(1 − α)
is the 1 − α quantile of a Chi-square distribution with k degrees of freedom and CDFχ2
k
(x) is
the cumulative distribution function of a Chi-square distribution with k degrees of freedom. The
following theorem shows that TmrAR(β0), TmrK(β0), and TmrCLR(β0) have asymptotically pivotal
distributions under the null H0 : β = β0.
Theorem 1. Suppose Assumptions 1- 4 and H0 : β = β0 hold. For any α ∈ (0, 1), as n1, n2 →
∞, n1/n2 → c ∈ (0,∞), we have
P
(
TmrAR > χ
2
L(1− α)
)→ α, P (TmrK > χ21(1− α))→ α, P (w(TmrCLR;QR) < α)→ α,
where
w(x; y) = 1− 2G
(
L
2
)
√
πG
(
L−1
2
) 1∫
0
CDFχ2
L
(
x+ y
1 + y z
2
x
)
(1− z2)L−32 dz
and G(·) is the gamma function.
Theorem 1 shows that under H0 : β = β0, the two-sample summary data versions of the AR,
K, and CLR tests converge to the classical null distributions for the three tests under the single-
sample individual data setting. In particular, like the original CLR test, mrCLR test requires
solving the integral w(x; y) to obtain critical values; this integral can be computed by using off-the-
shelf numerical integral solvers. We can also use the duality between tests and confidence intervals
to derive asymptotically valid 1− α confidence intervals for each test.
In the supplementary materials, we extend these results and construct a point estimator based
on minimizing the mrAR test statistic. We show that when the estimated covariance matrices Σ̂Γ
and Σ̂γ are diagonal, β̂mrLIML is equivalent to the estimator proposed by Zhao et al. (2018).
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3 Simulations
We conduct simulation studies to study the performance of our test statistics. The data is generated
from the structural model in (1) with n1 = n2 = 100, 000, on the same order as the sample size in the
data analysis section 4. The random error (δ1i, δ2i) is generated from a bivariate standard Normal
and the random error ǫli is equal to ǫli = ρδli + (1− ρ2)1/2eli; the term eli is from an independent
standard Normal and ρ = 0.1. We remark that ρ signifies the endogeneity between the outcome and
the exposure. The L = 10 instruments take on values 0, 1, 2, similar to how SNPs are recorded in
GWAS, and are generated independently from a Binomial distribution Binom(2, pj), j = 1, · · · , L
with pi drawn from a uniform distribution Unif(0.1, 0.9). After generating individual-level data,
we compute the summary statistics for sample l = 1, Γ̂ and Σ̂Γ, by running an OLS regression
between Y1i and Z1ij for each instrument j and extracting the estimated coefficient and standard
error. Similarly, we compute the summary statistics for sample l = 2, γ̂ and Σ̂γ , by running an OLS
regression between D2i and Z2ij for each instrument. The simulation varies the exposure effect β
and the IV-exposure relationship γ. The simulation is repeated 1, 000 times.
We examine the power of our proposed tests, TmrAR, TmrK, and TmrCLR and the power of existing
tests in MR, specifically tests based on the IVW estimator, MR-Egger regression, the W.Median es-
timator, all implemented in the software Mendelianrandomization (Yavorska and Burgess, 2017),
and MR-RAPs without the robust loss function (Zhao et al., 2018). Figure 1 shows the power
curves when the null hypothesis is H0 : β = 0 (left panel) or H0 : β = 1 (right panel); significance
level is set at α = 0.05. The top panels shows the case when γ ranges from {(r − 0.5)/n1}1/2 to
{(r + 0.5)/n1}1/2 and r = 1 the bottom panel shows the case when r = 4; the value r approx-
imately corresponds to the first-stage F-statistic test typically used to test instrument strength.
Under H0 : β = 0, all tests correctly control Type I error under r = 1 and r = 4. But, our three
tests, IVW, and MR-RAPs have power under r = 1 and r = 4 cases, with TmrCLR having the best
power among them; this is in agreement with Andrews et al. (2006) who showed that the CLR
test in the single-sample individual data setting is nearly optimal. Under H0 : β = 1, none of the
pre-existing methods except MR-RAPs have Type I error control when instruments are weak. In
contrast, our tests always maintain Type I error control. Also, our tests have power under the
alternative, with TmrCLR having the best power among them. In fact, in the supplementary mate-
rials, we show that tests based on the IVW estimator, weighted median estimator, and MR Egger
regression only locally control Type I error at the null H0 : β = 0 when the instruments are weak.
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Figure 1: Power curves under different null and IV strength. The left panel is under H0 : β0 = 0 and the
right panel is under H0 : β = 1. The top panel sets instrument strength to r = 1 and the bottom panel sets
instrument strength to r = 4; r approximately corresponds to the first-stage F-statistic test for IV strength.
4 Data Analysis
We validate our proposed tests by considering a prototypical MR study on the relationship between
BMI and systolic blood pressure where the exposure effect is known to be positive. We use the data
set prepared by Zhao et al. (2018) where the authors used three independent GWAS, one from the
UK Biobank GWAS (SBP-UKBB) and the other two from GWAS by the Genetic Investigation of
ANthropometric Traits (GIANT) consortium (Locke et al., 2015). The BMI-MAL and SBP-UKBB
datasets provide summary statistics of the IV-exposure and IV-outcome statistics, respectively.
The BMI-FEM dataset is a selection GWAS containing summary statistics of the IV-exposure
relationship and is used to pre-screen for strong and uncorrelated IVs.
We conduct two types of analysis with the data. First, we use the data as provided and examine
differences between the IVW, weighted median, MR-Egger estimator, MR-RAPS with a robust loss
function, and our methods when either L = 25 or L = 160 instruments are used. The results are
in Table 1.
We see that almost all methods provide similar 95% confidence intervals. Even though the
weighted median, MR-RAPS, and MR-Egger are robust to invalid instruments, their confidence
intervals are similar to confidence intervals from TmrK and TmrCLR, which are not robust to invalid
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Table 1: MR study concerning the effect of body mass index on systolic blood pressure. Parentheses
represent 95% confidence intervals.
25 Instruments 160 Instruments
mrK (0.205, 0.530) (0.377, 0.771)
mrCLR (0.211, 0.524) (0.415, 0.731)
mrAR (∅) (∅)
IVW 0.332 (0.063, 0.600) 0.317 (0.101, 0.534)
W.Median 0.520 (0.280, 0.759) 0.522 (0.318, 0.726)
MR-Egger 0.622 (0.101, 1.143) 0.452 (0.112, 0.792)
MR-RAPS 0.354 (0.097, 0.610) 0.378 (0.141, 0.615)
instruments. This suggests either that invalid instruments play a minimal role in this data or, as
Small and Rosenbaum (2008) suggests, in the presence of invalid IVs, the first-order bias comes
not from invalid IVs, but from weak IVs. This is also based on the observation that mrK produced
two split intervals, one in the negative region (-14.375, -10.905) (when L = 25) or (-10.376, -6.447)
(when L = 160) and the other in the positive region. We only report the positive region in Table
1 since we know a priori that the effect is positive; when the exposure effect direction is unknown,
we recommend taking the union of the intervals. Surprisingly, TmrAR produces an empty interval.
This behavior may be an indication that the model is incorrect or that the test lacks power; we
plan on investigating this property of TmrAR in future work.
Second, inspired by Bound et al. (1995), we “stress-test” the pre-existing methods and replace
each of the original IV-exposure effect γ̂j in BMI-MAL and the IV-outcome effect Γ̂j in SBP-UKBB
by the values generated below.
γ̂newj ∼ N(Kγ̂j, Σ̂γ,j), Γ̂newj ∼ N(Kγ̂jβ, Σ̂Γ,j)
Here, β is the true exposure effect and is set to be 0.5 and 1.5. The parameter K controls IV
strength and ranges from 0 to 1. Under K = 1, the new IV-exposure and IV-outcome effects are
essentially the original effects, but with a known exposure effect value β. But, as K decreases
to 0, the IV becomes weaker than the original ones. In the extreme case when K = 0, there is
no way to consistently estimate β; the new IV-exposure and IV-outcome effects look statistically
indistinguishable if the true exposure effect is β = 1 or β = 1000.
An ideal confidence interval should be able to (i) simultaneously and automatically detect the
lack of identification of the exposure effect β by producing an infinite confidence interval whenK = 0
and a bounded confidence intervals as K moves away from zero and (ii) for all values of K, provide
95% coverage. As Figure 2 shows, when we run the existing MR methods, none of them achieve
8
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Figure 2: Coverage probability under different IV strength. The left panel sets the true causal effect β to
be 0.5 and the right panel sets β to be 1.5.
these two goals. At K = 0, they always produce bounded confidence intervals, even though there is
no way to identify the exposure effect from data. Specifically, when K = 0, β = 0.5, the confidence
interval given by Weighted median, IVW, MR-Egger and MR-RAPS are (-0.624, 0.321), (-0.411,
0.265), (-0.527, 0.624), and (-0.460, 0.020), respectively. They are bounded and only the confidence
interval generated from MR-Egger covers the true effect β = 0.5. But TmrAR, TmrK, TmrCLR produce
unbounded confidence intervals. We observe a similar phenomena when K = 0 and β = 1.5: the
confidence intervals generated from Weighted median, IVW, MR-Egger and MR-RAPS are (-0.385,
0.547), (-0.312, 0.330), (-0.826, 0.317), and (-0.575, 0.942), respectively. All of them are bounded
and fail to cover the true causal effect, but our tests produce unbounded confidence intervals. Also,
when K is near zero so that the IV-exposure is sufficiently weak, all methods except MR-RAPS
fail to achieve 95% coverage. In contrast, our tests always satisfy the two criterions (i) and (ii).
They automatically produce infinite confidence intervals when K = 0 to alert the researcher about
lack of identification and produce bounded intervals as K moves away from zero. They also always
maintain 95% coverage for any value of K. In short, our proposed tests adapt to the data and
always produce honest intervals regardless of the underlying instrument strength.
5 Conclusion
In this paper, we propose weak-IV robust test statistics for two-sample summary data in MR. We
extend the existing AR, Kleibergen, and CLR tests in econometrics and show that it has the same
Type I error control under weak instrument asymptotics. The numerical results show that the
proposed tests, especially the mrCLR test, have better size control and power compared to current
methods when the instruments are weak. Additionally, when we stress-test different methods, our
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methods, especially the CLR test, adapts to the underlying instrument strength and provides valid
95% coverage. In practice, we recommend MR investigators use the mrCLR test to test exposure
effects as it provides valid confidence intervals regardless of IV strength. The code to implement
our tests is in the supplementary materials.
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Supplementary Materials for ”Weak-Instrument Robust Tests in
Two-Sample Summary-Data Mendelian Randomization”
Abstract
In this supplementary material for the paper Weak-Instrument Robust Tests in Two-Sample
Summary-Data in Mendelian Randomization, we propose a set of robust point estimators for the
exposure effect and provide additional results for simulation in Section 4 of the main manuscript.
We also prove our results in the main paper.
1 Robust Point Estimators for the Exposure Effect β
In this section, we extend the LIML estimator (Anderson et al., 1949) and the recent unbiased
estimator under known signs (Andrews and Armstrong, 2017) to the two-sample summary data
setting. We make the same assumptions on the summary statistics as in Section 2 of the main
manuscript
Assumption 1. The IV-exposure effect γ̂ and the IV-outcome effect Γ̂ are independent, γ̂ ⊥ Γ̂.
Assumption 2. The two effect estimates follow γ̂ ∼ N(γ,Σγ), Γ̂ ∼ N(γβ,ΣΓ)
Assumption 3. We have n1(Σ̂Γ−ΣΓ) p→ 0, n2(Σ̂γ −Σγ) p→ 0 and n1ΣΓ p→ Σ1, n2Σγ p→ Σ2, where
Σ1,Σ2 are deterministic positive-definite matrices.
Assumption 4. For some constant C ∈ RL, we have γ = C/√n1
In the single-sample individual-data setting, the limited information maximum likelihood(LIML)
estimator is a likelihood-based estimator of β by Anderson et al. (1949) that exhibits robustness
under many weak instruments (Stock and Yogo, 2005; Chao and Swanson, 2005) where in addition
to Assumption 4, the number of instruments is allowed to grow at a certain rate. Additionally, in
the one-sample individual-data setting, the LIML estimator is equivalent to the minimum of the
Anderson-Rubin test (Stock et al., 2002).
1
Following the construction of the original LIML, we also propose a point estimator for β, which
we denote it as β̂mrLIML as the solution to the minimum of the two-sample summary data AR test
TmrAR(β0), i.e.
β̂mrLIML := argminβTmrAR(β0) (1)
When the estimated covariance matrices Σ̂Γ and Σ̂γ of the effect estimates are diagonal, β̂mrLIML
is equivalent to the estimator proposed by Zhao et al. (2018). But, our formulation can handle
non-diagonal covariance matrices, i.e. when either the instruments or the marginal effects are
correlated. To evaluate β̂mrLIML, we can (i) do a simple grid search since β is a scalar parameter or
(ii) gradient descent where the local minimum can be found by iteratively taking steps proportional
to the negative of first-order derivative of TmrAR(β0).
The next estimator is based on an assumption that the sign of the effect of the instrument on
the exposure is known a prioiri. For example, in an MR study by Kang et al. (2016) concerning the
study of the effect of malaria (i.e. exposure) on stunted growth (i.e. outcome) in children in sub-
Saharan Africa, the authors used a gene, known as the sickle cell trait, as an instrument. It was well-
known biologically that carrying a copy of this trait reduced malarial infections, or more precisely,
the sign of the IV-exposure γ was known a priori. A recent work by Andrews and Armstrong (2017)
proposed an unbiased estimator of the exposure effect β provided that the sign of the IV-exposure
is known and the standard errors of the estimates are known. Unfortunately, their work was limited
to the one-sample individual-data setting.
We build on this recent work and the work by Voinov and Nikulin (2012), where the latter
proposed an unbiased estimator for the inverse of the mean parameter in Normally distributed
data, and propose a two-sample summary data variant of the unbiased estimator. Let CDFN(x)
and PDFN(x) denote the cumulative distribution function and the probability density function,
respectively, of the standard Normal distribution. For two-sample summary data setting and each
IV j, consider the following estimator β
β̂j,U =
Γ̂j√
Σjj,γ
·
1− CDFN
(
γ̂j√
Σjj,γ
)
PDFN
(
γ̂j√
Σjj,γ
) , (2)
where Σjj,γ is the j diagonal element of Σγ . Theorem 1 shows that the estimator is unbiased when
the sign of γj and the standard error of γ̂j are known.
Theorem 1. Suppose assumptions 1 and 2 hold where, without loss of generality, γj > 0. Then if
Σjj,γ is known, β̂j,U in equation (2) is an unbiased estimator of β.
Applying Theorem 1 in practice requires plugging in an estimator of the standard error of Σjj,γ
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Figure 1: Power Curves under Different number of IVs and IV Strength. Null: 0. The top panel sets the
number of instrument to L = 5 and the bottom panel sets the number of instruments to L = 10; The left
panel sets instrument strength to r = 1, the middle panel sets instrument strength to r = 4 and the right
panel sets instrument strength to r = 16; r approximately corresponds to the first-stage F-statistic test for
IV strength.
and with modern MR involving tens of thousands samples, Σjj,γ can be accurately estimated. Also,
because Theorem 1 holds for each instrument j, when multiple instruments are available, we can
aggregate β̂j,Us to obtain a single unbiased estimator. For example, any linear combination of β̂j,U
is still unbiased for β. In our numerical works, we opt to use the simple average to aggregate our
L unbiased estimates, β̂U =
1
L
L∑
j=1
β̂j,U
2 Extended Simulation Results
In this section, we provide extended simulation results to Section 3 of the main manuscript. The
data generating process is the same as the main manuscript.
We first examine the performance of our proposed tests TmrAR, TmrK, and TmrCLR, as well
as existing tests in MR, specifically tests based on the IVW estimator, MR-Egger regression, the
W.Median estimator, all implemented in the software Mendelianrandomization (Yavorska and Burgess,
2017), and MR-RAPs without the robust loss function (Zhao et al., 2018). Figure 1 shows the power
curves under the null hypothesis H0 : β = 0. Each graph uses a different pair of (L, r). The top
panel shows the case when L = 5 and the bottom panel L = 10. The IV strength is set as r = 1, 4, 16
respectively in the left, middle and right panel. All the methods correctly control Type I error. But,
our three tests, IVW, and MR-RAPS have power under r = 1 and r = 4 (when the instruments are
weak), with TmrCLR having the best power among them; this is in agreement with Andrews et al.
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Figure 2: Power Curves under Different number of IVs and IV Strength. Null: 1. The top panel sets the
number of instrument to L = 5 and the bottom panel sets the number of instruments to L = 10; The left
panel sets instrument strength to r = 1, the middle panel sets instrument strength to r = 4 and the right
panel sets instrument strength to r = 16; r approximately corresponds to the first-stage F-statistic test for
IV strength.
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Figure 3: Size Curves under Different number of IVs and IV Strength. The top panel sets the number of
instrument to L = 5 and the bottom panel sets the number of instruments to L = 10; The left panel sets
instrument strength to r = 1, the middle panel sets instrument strength to r = 4 and the right panel sets
instrument strength to r = 16; r approximately corresponds to the first-stage F-statistic test for IV strength.
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Figure 4: Absolute Median Bias of Point Estimators. The top panel sets the number of instrument to L = 5
and the bottom panel sets the number of instruments to L = 10; The left panel sets instrument strength to
r = 1, the middle panel sets instrument strength to r = 4 and the right panel sets instrument strength to
r = 16; r approximately corresponds to the first-stage F-statistic test for IV strength.
(2006) who showed that the CLR test in the single-sample individual data setting is nearly optimal.
When the instruments are relatively stronger (r = 16), all methods except MR-Egger have power
and TmrCLR has the best power among them. Figure 2 shows the power curves under H0 : β = 1.
In this scenario, none of the pre-existing methods except MR-RAPs have Type I error control when
instruments are weak while our tests always maintain Type I error control. Also, our tests have
power under the alternative, with TmrCLR having the best power among them. Figure 3 shows the
Type I error under H0 : β = β0 with β0 ranging from −2 to 2. All the tests are carried out under
the null. The size distortion of all the pre-existing methods increases as the true exposure effect
β moves away from 0, but our tests always have size control. Overall, we find that our proposed
tests are superior to pre-existing MR methods, especially under weak instruments, with respect to
Type I error control and power and TmrCLR has the best power in all simulated scenarios.
Second, we examine the performance of our point estimators, β̂mrLIML and the β̂U and compare
it against the same set of pre-existing MR methods; for the unbiased estimator, we assume that the
sign of each IV-exposure effect is positive. The simulation setting is the same as before, except we
vary the true exposure effect β from −2 to 2. We measure the absolute median bias and the median
absolute deviation (MAD) of all the estimators and the results are shown in Figure 4 and Figure 5.
In terms of absolute median bias, our LIML estimator and unbiased estimator are less biased than
pre-existing methods, with the notable exception to MR-RAPS; we also find that LIML is the
least biased overall. Also, similar to the testing case, as the true exposure effect moves away from
zero, the IVW estimator, the weighted median estimator , MR-Egger estimator, and the unbiased
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Figure 5: MAD of Point Estimators. The top panel sets the number of instrument to L = 5 and the
bottom panel sets the number of instruments to L = 10; The left panel sets instrument strength to r = 1,
the middle panel sets instrument strength to r = 4 and the right panel sets instrument strength to r = 16;
r approximately corresponds to the first-stage F-statistic test for IV strength.
estimator are biased; in contrast, LIML is unaffected by the value of β. With respect to median
absolute deviation, all methods are similar around 0. But with larger |β|, the MAD of the LIML,
MR-RAPs, and the unbiased estimator are smaller than the IVW, weighted median, and MR-Egger
estimators.
3 Proof of Lemmas and Theorems
Proof of Lemma 1.
Define
S˜(β0) =
(
ΣΓ + β
2
0Σγ
)−1/2 (
Γ̂− β0γ̂
)
,
R˜(β0) = (β
2
0Σ
−1
Γ
+Σ−1γ )
−1/2
(
Σ−1
Γ
Γ̂β0 +Σ
−1
γ γˆ
)
Let d1 = Γˆ− Γ, d2 = γˆ − γ, then we have
S˜(β0) = (ΣΓ + β
2
0Σγ)
−1/2[Γˆ, γˆ]b0
= (n1ΣΓ + n1β
2
0Σγ)
−1/2n1/21 (IL,−β0IL)[vec(Γ, γ) + vec(d1, d2)]
p→ (Σ1 + cβ20Σ2)−1/2(β − β0)C + (ΣΓ + β20Σγ)−1/2(IL,−β0IL)vec(d1, d2) ≡ S∞
∼ N((Σ1 + cβ20Σ2)−1/2(β − β0)C, IL)
6
R˜(β0) = (β
2
0Σ
−1
Γ
+Σ−1γ )
−1/2(Σ−1
Γ
β0,Σ
−1
γ )vec(Γˆ, γˆ)
= (β20n
−1
1 Σ
−1
Γ
+ n−11 Σ
−1
γ )
−1/2[n−11 Σ
−1
Γ
β0, n
−1
1 Σ
−1
γ ]n
1/2
1 vec(Γ, γ) + (β
2
0Σ
−1
Γ
+Σ−1γ )
−1/2[Σ−1
Γ
β0,Σ
−1
γ ]
vec(d1, d2)
p→ (β20Σ−11 + c−1Σ−12 )−1/2[β0βΣ−11 C + c−1Σ−12 C] + (β20Σ−1n,Γ +Σ−1n,γ)−1/2(Σ−1n,Γβ0,Σ−1n,γ)vec(d1, d2) ≡ R∞
∼ N((β20Σ−11 + c−1Σ−12 )−1/2(β0βΣ−11 C + c−1Σ−12 C), IL)
Since n1(ΣˆΓ − ΣΓ) p−→ 0, n2(Σˆγ − Σγ) p−→ 0, we have that ((S(β0), R(β0)) − (S∞, R∞)) p−→ 0.
The asymptotic normal distributions of Sn and Rn are independent because they are non-stochastic
functions of (ΣΓ+β
2
0Σγ)
−1/2(IL,−β0IL)vec(d1, d2) and (β20Σ−1Γ +Σ−1γ )−1/2(Σ−1Γ β0,Σ−1γ )vec(d1, d2),
and
Cov((ΣΓ + β
2
0Σγ)
−1/2(I ′L,−β0I ′L)vec(d1, d2), (β20Σ−1Γ +Σ−1γ )−1/2(Σ−1Γ β0,Σ−1γ )vec(d1, d2))
= (ΣΓ + β
2
0Σγ)
−1/2(IL,−β0IL)
(
ΣΓ 0
0 Σγ
)
(Σ−1
Γ
β0,Σ
−1
γ )
′(β20Σ
−1
Γ
+Σ−1γ )
−1/2
= 0.
Proof of Theorem 1.
Let Q∞ =
(
Q∞,S Q∞,RS
Q∞,SR Q∞,R
)
=
(
S′∞S∞ R
′
∞S∞
S′∞R∞ R
′
∞R∞
)
, S2 = Q∞,SR/(Q∞,SQ∞,R)1/2.
By lemma 1, Q∞,S follows χ2L under H0. Since TmrAR
p−→ Q∞,S, we have that P (TmrAR >
χ2L(1 − α)) → α. Similarly, since Q2∞,SR/Q∞,R follows χ21 under H0, and TmrK
p−→ Q2∞,SR/Q∞,R,
we have that P (TmrK > χ
2
1(1− α))→ α.
For TmrCLR =
1
2
(QS −QR+((QS +QR)2− 4(QSQR−Q2SR))1/2), let LR∞ = 12(Q∞,S −Q∞,R+
((Q∞,S +Q∞,R)2 − 4(Q∞,SQ∞,R −Q2∞,SR))1/2). By Lemma 1, TmrCLR
p−→ LR∞.
Let w(x; qr) = P0(LR∞ > x|Q∞,R = qr) = 1 − 2G(
L
2
)√
piG(L−1
2
)
1∫
0
CDFχ2
L
(
x+qr
1+qr
z2
x
)
(1 − z2)L−32 dz,
where P0 denotes the probability evaluated under H0. We reject H0 if w(TmrCLR;QR) is smaller
than α. Our goal is to show that lim
n1,n2→∞
P (w(TmrCLR;QR) < α) = α when H0 is true.
Denote F0,qr(LR∞) = w(LR∞, qr) as the conditional CDF of LR∞ given Q∞,R = qr. Under
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H0, we have
lim
n1,n2→∞
P (w(TmrCLR;QR) < α|Q∞,R = qr) = lim
n1,n2→∞
P0(w(TmrCLR; qr) < α|Q∞,R = qr)
= lim
n1,n2→∞
P0(F0,qr(TmrCLR) < α|Q∞,R = qr)
= P0(F0,qr(LR∞) < α|Q∞,R = qr) = α
lim
n1,n2→∞
P0(w(TmrCLR;QR) > α) = lim
n1,n2→∞
∫
P0(w(TmrCLR;QR) > α|Q∞,R = qr)fQ∞,R(qr)dqr
=
∫
lim
n1,n2→∞
P0(p − value > α|Q∞,R = qr)fQ∞,R(qr)dqr
=
∫
(1− α)fQ∞,R(qr))dqr = 1− α
where the exchange of the limit and integral in the second last equality is guaranteed by Dominated
Convergence Theorem.
Proof of Theorem S.1.
Let τˆ(γ̂j ,Σjj,γ) =
1√
Σjj,γ
·
1−CDFN
(
γ̂j√
Σjj,γ
)
PDFN
(
γ̂j√
Σjj,γ
) . Since γ̂j√
Σjj,γ
∼ N( γ√
Σjj,γ
, 1), we have
E(τˆ (γ̂j ,Σjj,γ)) =
1√
Σjj,γ
E
1− CDFN(γ̂j/
√
Σjj,γ)
PDFN(γ̂j/
√
Σjj,γ)
=
1√
Σjj,γ
∫
1− CDFN(x)
PDFN(x)
PDFN(x− γ√
Σjj,γ
)dx
=
1√
Σjj,γ
∫
(1− CDFN(x)) exp((γ1/
√
Σjj,γ)x− (γ1/
√
Σjj,γ)
2/2)dx
=
1
γ1
exp(−(γ1/
√
Σjj,γ)
2/2)
∫
(1− CDFN(x))d(exp((γ1/
√
Σjj,γ)x))
=
1
γ1
exp(−(γ1/
√
Σjj,γ)
2/2){[(1 − CDFN(x)) exp(γ1/
√
Σjj,γ)x]
∞
x=−∞
+ exp((γ1/
√
Σjj,γ)x)PDFN(x)dx}
=
1
γ1
exp(−(γ1/
√
Σjj,γ)
2/2)
∫
exp((γ1/
√
Σjj,γ)x)
1√
2pi
exp(−x
2
2
)dx
=
1
γ1
∫
1√
2pi
exp(−(x− γ1/
√
Σjj,γ)
2
2
)dx
=
1
γ1
Thus E(β̂j,U) = E(Γ̂j τˆ(γ̂j ,Σjj,γ)) =
Γj
γj
by independence between Γ̂j and γ̂j.
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